Future studies exploring the functional role of specific HLA-C alleles in IFN-γ/IL-17-dependent immune responses will be fundamental not only to unveil their pathogenic activity in psoriasis but also to understand why specific HLA-C haplotypes effectively respond to the ustekinumab treatment. This evidence concerns the gene IL17A and psoriasis.